Cargando…

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy

Head and neck squamous cell carcinomas (HNSCC) are a heterogeneous group of malignant tumours typically caused by alcohol and tobacco consumption, although an increasing number of HNSCC arise due to persistent infection with high-risk human papilloma virus (HPV). The treatment of HNSCC remains chall...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Witzleben, Adrian, Wang, Chuan, Laban, Simon, Savelyeva, Natalia, Ottensmeier, Christian H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564543/ https://www.ncbi.nlm.nih.gov/pubmed/32942747 http://dx.doi.org/10.3390/cells9092103

Ejemplares similares

Plant Virus Particles Carrying Tumour Antigen Activate TLR7 and Induce High Levels of Protective Antibody
por: Jobsri, Jantipa, et al.
Publicado: (2015)

Changes in Gene Expression Patterns in the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma Under Chemoradiotherapy Depend on Response
por: Doescher, Johannes, et al.
Publicado: (2022)

Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy
por: Puntigam, Lisa K., et al.
Publicado: (2020)

Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer
por: McCann, Katy, et al.
Publicado: (2022)

Review of biomarkers for response to immunotherapy in HNSCC microenvironment
por: Chen, Shaoshi, et al.
Publicado: (2023)

Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC
por: von Witzleben, Adrian, et al.
Publicado: (2021)

The neoadjuvant paradigm reinvigorated: a review of pre-surgical immunotherapy in HNSCC
por: Stafford, Margaret, et al.
Publicado: (2020)

CAR Based Immunotherapy of Solid Tumours—A Clinically Based Review of Target Antigens
por: Maher, John, et al.
Publicado: (2023)

Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
por: Leger, Stefan, et al.
Publicado: (2020)

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy
por: Sha, Huan-huan, et al.
Publicado: (2017)

Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens
por: Gubin, Matthew M., et al.
Publicado: (2014)

Antigen Targets for the Development of Immunotherapies in Leukemia
por: Bauer, Jens, et al.
Publicado: (2019)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
por: Cohen, Ezra E. W., et al.
Publicado: (2019)

Cancer immunotherapy: broadening the scope of targetable tumours
por: van den Bulk, Jitske, et al.
Publicado: (2018)

lncRNA in HNSCC: challenges and potential
por: Guglas, Kacper, et al.
Publicado: (2017)

Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019)

Impact and Relevance of the Unfolded Protein Response in HNSCC
por: Pluquet, Olivier, et al.
Publicado: (2019)

Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice
por: Brand, Matthias, et al.
Publicado: (2020)

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection
por: Sharon, Shay, et al.
Publicado: (2021)

Analyzing expression and phosphorylation of the EGF receptor in HNSCC
por: Kriegs, Malte, et al.
Publicado: (2019)

Protein-Based Oncopanel as Addition to Target Sequencing in Head and Neck Squamous Cell Carcinoma to Individualize Treatment Decisions
por: von Witzleben, Adrian, et al.
Publicado: (2022)

Intratumoural administration and tumour tissue targeting of cancer immunotherapies
por: Melero, Ignacio, et al.
Publicado: (2021)

How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies
por: Nardone, Valerio, et al.
Publicado: (2018)

Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity
por: Chi, Hao, et al.
Publicado: (2023)

Incidence and survival of HNSCC patients living with HIV compared with HIV-negative HNSCC patients
por: Haase, Katharina, et al.
Publicado: (2021)

Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours
por: Chruściel, Elżbieta, et al.
Publicado: (2020)

Metabolic syndrome – Removing roadblocks to therapy: Antigenic immunotherapies()
por: Coppieters, Ken T., et al.
Publicado: (2014)

Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)
por: Jung, Kyungsuk, et al.
Publicado: (2018)

Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC
por: Mann, JE, et al.
Publicado: (2017)

Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma
por: Cho, Shih-Feng, et al.
Publicado: (2021)

Comprehensive Analysis of mTORC1 Signaling Pathway–Related Genes in the Prognosis of HNSCC and the Response to Chemotherapy and Immunotherapy
por: Ding, Zhao, et al.
Publicado: (2022)

Targeting Head and Neck Cancer by Vaccination
por: Wang, Chuan, et al.
Publicado: (2018)

Advancing Understanding of Non-Small Cell Lung Cancer with Multiplexed Antibody-Based Spatial Imaging Technologies
por: Gray, Simon, et al.
Publicado: (2023)

Planned neck dissection following chemo-radiotherapy in advanced HNSCC
por: Gupta, Tejpal, et al.
Publicado: (2004)

Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
por: De Sanctis, Francesco, et al.
Publicado: (2022)

CAR-Based Immunotherapy of Solid Tumours—A Survey of the Emerging Targets
por: Maher, John, et al.
Publicado: (2023)

A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC
por: Ding, Yinghe, et al.
Publicado: (2023)

Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC
por: Gong, Xiangjin, et al.
Publicado: (2023)

DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor
por: Wang, Chuan, et al.
Publicado: (2021)

Fewer tumour-specific PD-1(+)CD8(+) TILs in high-risk “Infiltrating” HPV(−) HNSCC
por: Xu, Ke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l5l3fp4mflth5vtgscu355rc9s